top of page

Biostatistics Expertise

  • Adaptive Trial Design - Design and implementation of the next generation of biostatistics 

  • Recurrent Events Analysis - Making effective use of critical study endpoints

  • Meta-Analysis - Efficient combinations of critical data from muliple datasets

  • Modeling and Simulation - Evaluating the robustness and validity of trial designs

  • Independent statistician on Data and Safety Monitoring Boards and support at regulatory meetings worldwide

Therapeutic Experience

Type-2 diabetes, schizophrenia, depression, stroke and Alzheimer's disease - Breast Cancer, Cervical Cancer, Leukemia, Hodgkin's Disease, Prostate, Sarcoma, Non-small Cell Lung Cancer - Infectious Diseases (Anti-Bacterial and HIV/AIDS, CMV, HSV, HCV) - Local Anesthetics and Analgesics - Cardiology - Urology - Rheumatoid Arthritis - Neurology - Psoriasis

Elite Status Expert with IMS ExpertServices

Learn more

Our Recent Research Projects


Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

LEADER Trial Investigators

Efficacy of Plinabulin vs Pegfilgrastim for Prevention
of Chemotherapy-Induced Neutropenia in Adults
With Non–Small Cell Lung Cancer- A Phase 2 Randomized Clinical Trial

JAMA Oncology

Degludec versus Glargine in Type 2 Diabetes DEVOTE

DEVOTE Study Group

Designing and Analyzing Recurrent Event Data Trials

Stephan Ogenstad

Generalized Tests in Clinical Trials

Stephan Ogenstad

A Statistical Approach to Clinical Trial Simulations

Stephan Ogenstad

bottom of page